Verdane, a specialist growth equity investment firm, completed the acquisition of a minority stake in Qbtech, a software provider of objective ADHD tests. Financial terms were not disclosed. “Verdane is an experienced investor in healthcare software, and we look forward to partnering with Qbtech at this pivotal moment in their growth journey. Qbtech offers a unique technology that is driving the standard for clinical validation and advancing new technologies at pace. Our team has been impressed by their ground-breaking, innovative technologies that improve care, reduce healthcare costs, and provide an amazing experience for patients and their families," Henrik Aspén, Verdane Partner.